blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0532190

EP0532190 - Benzo(f)quinolinones as 5-alpha-reductase inhibitors [Right-click to bookmark this link]
Former [1993/11]Benzo f quinolinones as 5-alpha-reductase inhibitors
[2000/15]
StatusNo opposition filed within time limit
Status updated on  02.11.2001
Database last updated on 02.08.2024
Most recent event   Tooltip02.11.2001No opposition filed within time limitpublished on 19.12.2001 [2001/51]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [1993/11]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / Audia, James Edmund
6649 Lakeside Woods Circle
Indianapolis, Indiana 46278 / US
02 / Hirsch, Kenneth Steven
6473 Haviland Mill Road
Clarksville, Maryland 21029 / US
03 / Jones, Charles David
223 East Brunswick Avenue
Indianapolis, Indiana 46227 / US
04 / Lawhorn, David Ernest
709 Noth Wilson Street
Greenfield, Indiana 46254 / US
05 / McQuaid, Loretta Ames
7504 Runningbrook Court
Indianapolis, Indiana 46254 / US
06 / Weigel, Leland Otto
4927 Cherry Hill Lane
Indianapolis, Indiana 46254 / US
[1993/11]
Representative(s)Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham
Surrey GU20 6PH / GB
[N/P]
Former [1993/11]Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Application number, filing date92307637.620.08.1992
[1993/11]
Priority number, dateUS1991074811621.08.1991         Original published format: US 748116
US1991078103921.10.1991         Original published format: US 781039
US1992092771010.08.1992         Original published format: US 927710
[1993/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0532190
Date:17.03.1993
Language:EN
[1993/11]
Type: A3 Search report 
No.:EP0532190
Date:14.07.1993
Language:EN
[1993/28]
Type: B1 Patent specification 
No.:EP0532190
Date:27.12.2000
Language:EN
[2000/52]
Search report(s)(Supplementary) European search report - dispatched on:EP25.05.1993
ClassificationIPC:C07D221/10, C07C229/46, C07C49/747, A61K31/435
[1993/11]
CPC:
C07D221/10 (EP,US); C07D215/06 (KR); A61P13/08 (EP);
A61P17/00 (EP); A61P17/08 (EP); A61P17/10 (EP);
A61P17/14 (EP); A61P35/00 (EP); A61P43/00 (EP);
C07C227/16 (EP,US); C07C229/46 (EP,US); C07C41/16 (EP,US);
C07C45/00 (EP,US); C07C45/513 (EP,US); C07C45/562 (EP,US);
C07C49/697 (EP,US); C07C49/747 (EP,US); C07C49/755 (EP,US);
C07C49/792 (KR); C07C59/255 (EP,US); C07D215/00 (KR);
C07C2602/10 (EP,US); C07C2603/70 (EP,US) (-)
C-Set:
C07C227/16, C07C229/46 (US,EP);
C07C41/16, C07C43/202 (EP,US);
C07C45/00, C07C49/697 (EP,US);
C07C45/513, C07C49/67 (US,EP);
C07C45/562, C07C49/697 (US,EP)
(-)
Designated contracting statesDE,   FR,   GB,   IT [2000/34]
Former [1993/11]AT,  BE,  CH,  DE,  DK,  FR,  GB,  IE,  IT,  LI,  LU,  NL,  PT,  SE 
TitleGerman:Benzo(f)quinolinone als 5-Alpha-reductase Inhibitoren[1993/11]
English:Benzo(f)quinolinones as 5-alpha-reductase inhibitors[2000/15]
French:Benzo(f)quinolinones comme inhibiteurs de 5-alpha-réductase[1993/11]
Former [1993/11]Benzo f quinolinones as 5-alpha-reductase inhibitors
Examination procedure20.08.1992Examination requested  [1993/11]
29.01.1997Despatch of a communication from the examining division (Time limit: M06)
07.07.1997Reply to a communication from the examining division
13.01.1998Despatch of a communication from the examining division (Time limit: M06)
22.07.1998Reply to a communication from the examining division
16.11.1998Despatch of a communication from the examining division (Time limit: M04)
23.04.1999Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
15.06.1999Reply to a communication from the examining division
02.07.1999Despatch of a communication from the examining division (Time limit: M06)
12.01.2000Reply to a communication from the examining division
06.04.2000Despatch of communication of intention to grant (Approval: Yes)
06.07.2000Communication of intention to grant the patent
28.08.2000Fee for grant paid
28.08.2000Fee for publishing/printing paid
Opposition(s)28.09.2001No opposition filed within time limit [2001/51]
Request for further processing for:15.06.1999Request for further processing filed
15.06.1999Full payment received (date of receipt of payment)
Request granted
30.06.1999Decision despatched
Fees paidRenewal fee
05.07.1994Renewal fee patent year 03
07.07.1995Renewal fee patent year 04
26.07.1996Renewal fee patent year 05
21.07.1997Renewal fee patent year 06
04.07.1998Renewal fee patent year 07
10.08.1999Renewal fee patent year 08
07.08.2000Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0127597  (ASTRA LAEKEMEDEL AB [SE]);
 [A]EP0399159  (HOFFMANN LA ROCHE [CH])
    [ ] - JOURNAL OF MEDICINAL CHEMISTRY, vol. 33, no. 7, July 1990, pages 2000-2006, American Chemical Society, US; J.G. CANNON et al.: "Monomethyl ether derivatives of 7,8-dihydroxy- and 8,9-dihydroxy-4-n-propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines as possible products of metabolism by catechol-O-methyltransferase"
    [ ] - JOURNAL OF MEDICINAL CHEMISTRY, vol. 22, no. 4, April 1979, pages 341-347, American Chemical Society, US; J.G. CANNON et al.: "Rigid congeners of dopamine based on octahydrobenzo(f)quinoline: peripheral and central effects"
    [ ] - SYNTHESIS, no. 6, June 1986, pages 494-496, Georg Thieme Verlag, Stuttgart, DE; J.G. CANNON et al.: "Stereospecific route to trans-1,2,3,4a,5,6,10b-octahydrobenzo(f)quinolines"
    [ ] - JOURNAL OF MEDICINAL CHEMISTRY vol. 33, no. 7, July 1990, WASHINGTON pages 2000 - 2006 J.G. CANNON ET. AL.
    [ ] - JOURNAL OF CHEMISTRY vol. 22, no. 4, April 1979, WASHINGTON pages 341 - 347 J. G. CANNON ET. AL.
    [ ] - SYNTHESIS no. 6, June 1986, STUTTGART pages 494 - 496 J. G. CANNON ET. AL.
Examination   - TETRAHEDRON LETTERS vol. 29, no. 35, 1988, OXFORD pages 4427 - 4430 JEAN D¡ANGELO ET. AL.
    - TETRAHEDRON LETTERS vol. 28, no. 21, 1987, OXFORD pages 2367 - 2370 TONY VOLPE ET. AL.
    - CHEMICAL ABSTRACTS, vol. 78, no. 11, 19 March 1973, Columbus, Ohio, US; abstract no. 71780a, page 441 ;column R ;
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.